All Previous Events

Handeln med förfalskade läkemedel har ökat under de senaste åren, och även om Sverige hittills varit relativt förskonat vet vi inget om framtiden. Sätten att förfalska läkemedel är otaliga och risken att bli upptäckt liten. Att förfalskade läkemedel når Sverige via den vanliga läkemedelsimporten och i slutändan hamnar på de vanliga apotekens hyllor är ingen omöjlighet. Detta har exempelvis redan inträffat i Storbritannien.

Boken Coincidence or Crisis? beskriver problemet med läkemedelsförfalskning, dess omfattning och möjliga lösningar ur ett europeiskt perspektiv.

Boken presenteras av Graham Satchwell som är en av författarna. Efteråt följer en paneldiskussion om läget i Sverige och de internationella erfarenheterna. Hur allvarligt är problemet med illegala läkemedel och läkemedelsförfalskning och hur kan vi lära oss av andra länders erfarenheter?

Almost unthinkable 20 years ago, Sweden has seen rapid development of free schools in the past decade. Thanks to a voucher reform launched in 1993, anybody has the right to start pre-schools, primary, secondary and high schools. Money follows the pupil and schools may be run as cooperatives, foundations, companies or by individuals.

What are the limits and potential of free choice in education, and what is the impact on public schools of greater competition? This event will bring together Per Unckel, former minister of Education in Sweden and author of the reform, and Etienne Verhack, Secretary General of the European Committee for Catholic Education, to discuss the challenges in the growing market for private education. Stephen Pollard, President of the CNE will chair the event.

The business of creating, distributing and selling counterfeit pharmaceutical products is an unregulated, criminal and growing part of the global economy. There is one major difference between pharmaceutical counterfeiting and other underground industries: lives are at stake.

Coincidence or Crisis brings together some of the world’s leading experts to discuss the growth of counterfeit pharmaceuticals. It provides a comprehensive analysis of the core issues, while delimiting key strategies to tackle the problem.

REGISTRATION FOR THIS EVENT IS NOW CLOSED

What is David Cameron for? He downplays tax cuts, is socially liberal and believes in a muscular foreign policy (and voted for the Iraq war). He would like to reform public services to give consumers more choice, and to involve private companies and charities in providing them. Sound familiar? And if so, is that a bad thing? After all, policies like these have just won three elections in a row. Will the new Cameron era be a break with the past or a return to true-blue values? Is Mr Cameron just a softer, pre-Thatcher Tory with a dollop of belief in the possibility of progress added? Can he create a vision for the future which his entire party can support, or will he only serve to divide the party further? And would Britain governed by a Cameron-led Conservative Party feel very different to Britain today?

The Stockholm Network in association with Managing Intellectual Property Magazine and The Progress & Freedom Foundation has developed a new and innovative statistical index aimed at measuring the strength of IP rights in the IT sector in different countries.

In this event, we will launch the IP-IT Index for the first time and present its rationale, methodology and specific components, as well as the scores of some of the leading markets

As businesses and consumers struggle to adjust to high energy prices and threats to supply, the European Commission and many EU member states are drawing up new national strategies for energy. The European Commission considers the liberalisation of EU electricity and gas markets to be a key part of its Lisbon agenda to improve the performance of the European economy. Commission president José Manuel Barroso and Energy Commissioner Andris Piebalgs hope that reforms favouring free markets and liberal institutions will provide the right framework for investment and trade.

On the 25th October 2006 the WIPO Division on Small and Medium-sized Enterprises and the Stockholm Network Intellectual Property & Competition Programme will be hosting a seminar on the topic of IPRs, SMEs and public private partnerships at the WIPO headquarters in Geneva. The seminar will focus on the methods by which IPRs can be used by different SMEs - such as university tech-transfer bodies, research hospitals and spin-off companies - to form partnerships with larger companies in the biomedical field and develop new treatments and new medical technologies. The seminar will also study national and international policies which can encourage of the use of IPRs in private-public collaborations.

Registration for this event is required.
Please arrive early.

The business of creating, distributing and selling counterfeit pharmaceutical products is an unregulated, criminal and growing part of the global economy. There is one major difference between pharmaceutical counterfeiting and other underground industries: lives are at stake.

Coincidence or Crisis brings together some of the world’s leading experts to discuss the growth of counterfeit pharmaceuticals. It provides a comprehensive analysis of the core issues, while delimiting key strategies to tackle the problem.

With rising domestic consumption and the rapid drawing down of North Sea reserves, Britain is set to become a net importer of energy by 2020. During the same period, Russian provision of EU energy will rise to over 50% of total consumption. This energy relationship will therefore alter and dominate all bilateral (and EU-Russia) relations.

Russian energy policy, and its interaction with Russian foreign policy, will dominate European politics for the next fifty years. How should Britain react to this new challenge?

NB Registration is not required for this event. Please turn up on the day.

EU citizens travel more and more inside the Union, sometimes taking up residence outside of their country of origin for work, leisure or retirement. They are increasingly used to crossing frontiers, buying goods and services wherever they are. Mobile Europeans are also consumers of health care. As this mobility puts pressure on public systems, cross-border agreements have become necessary and they often offer innovative ideas for improving services.These include the euregios insurance cooperation, public/private contracting in tourist areas and hospital cooperation.
Is this nascent “shopping around” a sign of increased competition? How do public systems respond to health tourism? Is it a trend or a marginal phenomenon?